Genmab — Marts 2019

[Bulder]

Zacks er der vel for fanden ikke nogen der tager alvorligt.

[StockBull]

og deres P/E ratio of 63.20 må være baseret på 2018 tal eller Q1-2019 ?

[StockBull]

for snakker vi 2019 guiding er vi p.t under under PE40

[peter12]

Jeg tar dem alvorligt når de opjusterer. Ellers ikke...

[Helge_LarsenPI-redaktør]

[bibob]

Der er jo altid nogen der har en mission når de kommer med deres statement.

[AaBforever]

Jeps...vi kunne godt bruge et statement som fik den op..

[Bella1]

Lidt tilsætning af Sildenafil til Dara kunne nok få den op

[bibob]

Godt klaret med en omsætning på 200 mil og lande et minus på 0,50 øre.

[Bulder]

Under-the-skin https://myelomaresearchnews.com/2019/03/11/under-the-skin-form-as-effective-as-intravenous-darzalex-myeloma/?utm_source=Myeloma+List&utm_campaign=363be747ae-RSS_WEEKLY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_14fcd0022a-363be747ae-72491777

[Bulder]

Selinexor https://myelomaresearchnews.com/2019/03/08/fda-raises-concerns-safety-selinexor-myeloma/?utm_source=Myeloma+List&utm_campaign=363be747ae-RSS_WEEKLY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_14fcd0022a-363be747ae-72491777

[E_L]

Creating Lasting Benefit With CAR T-Cell Therapy in Myeloma
https://www.onclive.com/web-exclusives/creating-lasting-benefit-with-car-tcell-therapy-in-myeloma?p=1

[Helge_LarsenPI-redaktør]

God morgen.

[polle1]

God morgen og god dag

[transalp]

Go morgen derude..

[Helge_LarsenPI-redaktør]

https://play.borsen.dk/social/5c8643b3595ab4f00a32ff35

[E_L]

JNJ has announced that (NICE) has recommended Darzalex (daratumumab) plus Velcade (bortezomib) and dexamethasone (DVd) for use within the Cancer Drugs Fund (CDF), as an option for treating relapsed multiple myeloma in people who have had one previous treatment. https://pharmafield.co.uk/pharma_news/nice-nod-for-game-changing-treatment-via-cdf-for-uk-myeloma-patients/

[E_L]

on NICE https://www.nice.org.uk/guidance/indevelopment/gid-ta10174/documents

[E_L]

Cancer Research UK : ‘Game-changing’ myeloma drug combo approved for NHS use in England ‘Game-changing’ myeloma drug combo approved for NHS use in England

[E_L]

https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2019-03-12-game-changing-myeloma-drug-combo-approved-for-nhs-use-in-england